Investments
1Portfolio Exits
1
Want to inform investors similar to Cary Sucoff about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Cary Sucoff News
Feb 27, 2023
PHILADELPHIA--(BUSINESS WIRE)--Neuraptive Therapeutics, Inc., a biotechnology company dedicated to developing novel therapeutics and medical products to address the unmet needs of physicians and patients impacted by peripheral nerve injuries, announces the appointment of Cary Sucoff, J.D. to the company’s Board of Directors. “On behalf of the Neuraptive Board and its directors, we are excited to welcome Cary to the board,” said Robert Radie, chairman, and chief executive officer of Neuraptive.
Cary Sucoff Investments
1 Investments
Cary Sucoff has made 1 investments. Their latest investment was in ContraFect as part of their Series A on October 10, 2010.
Cary Sucoff Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
10/15/2010 | Series A | ContraFect | $2.2M | Yes |
Date | 10/15/2010 |
|---|---|
Round | Series A |
Company | ContraFect |
Amount | $2.2M |
New? | Yes |
Co-Investors | |
Sources |
Cary Sucoff Portfolio Exits
1 Portfolio Exit
Cary Sucoff has 1 portfolio exit. Their latest portfolio exit was ContraFect on July 29, 2014.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
7/29/2014 | IPO | Public | 1 |
Date | 7/29/2014 |
|---|---|
Exit | IPO |
Companies | |
Valuation | |
Acquirer | Public |
Sources | 1 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
